Study centers and investigators
The triangular test consisted in plotting every 100 observed deaths a statistic measuring the observed treatment difference in outcome, Z, against some variance estimate, V, thus relating estimated treatment effect relatively to the sample size information at each time point (data markers). Thresholds of significance (represented by the boundaries of the triangular plot) are constructed to allow conclusions to be made while controlling for type I error rate when crossed. The boundaries of the sequential plan (ie, the limits of the 2 zones shown in the graph) were drawn to demonstrate an absolute difference of 5% in 28-day mortality rate between the two treatment arms, assuming a 20% mortality rate in the crystalloids group, and with alpha and beta of 5% and 10% respectively. 
